St. Mary Medical Center is a hospital in Long Beach, California, US. It is currently operated by Dignity Health. SMMC has all private acute care rooms for patients.

There are 415 beds in St Mary Medical Center.

During the past decade, St Mary Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Mary Medical Center" #1 sponsor was "NSABP Foundation Inc" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Mary Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "St Mary Medical Center" are "Breast Cancer" (2 trials), "HIV Infections" (2 trials), "Colorectal Cancer" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Methicillin-resistant Staphylococcus Aureus" (1 trials). Many other conditions were trialed in "St Mary Medical Center" in a lesser frequency.

Most popular intervention types in "St Mary Medical Center" are "Drug" (5 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adriamycin" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials) and "Efavirenz" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Mary Medical Center" are 5 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "St Mary Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in St Mary Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St Mary Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".